Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA

Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA

US Patent 12227779 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound for modulating DDAH and ADMA levels, as well as methods of using thereo2024
Compound for modulating DDAH and ADMA levels, as well as methods of using thereo2022
Cerivastatin to treat pulmonary disorders2013